Dr. Heidi Overton Tapped to Lead FDA by President Trump
Dr. Heidi Overton, a deputy director of the White House Domestic Policy Council, has been selected by President Trump to lead the Food and Drug Administration.
Cleveland Akron, OH, August 19, 2026 —
President Trump has announced his selection of Dr. Heidi Overton to serve as the next head of the Food and Drug Administration (FDA). Dr. Overton currently holds the position of deputy director within the White House Domestic Policy Council.
The announcement marks a significant personnel decision for the federal agency responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation’s food supply, cosmetics, and products that emit radiation.
Dr. Overton’s background includes her recent role in the White House Domestic Policy Council, where she has been involved in shaping domestic policy initiatives. Details regarding her previous experience and specific qualifications for leading the FDA were not further elaborated upon in the announcement.
The transition at the helm of the FDA is a key development for the agency, which plays a crucial role in public health and regulatory oversight. Further information regarding the nomination process, including any required Senate confirmation hearings, is expected to be released in the coming weeks.
Story summarized from the original created by Associated Press on fox8.com, see more information here.
